| Biomarker ID | 754 |
| PMID | 21917134 |
| Year | 2011 |
| Biomarker | PAGE4 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in Patients with Recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | HR = 0.44, (95% CI: 0.21-0.93) |
| Effect on Pathways | NA |
| Experiment | PSA Reccurence Vs No Recurrence |
| Type of Biomarker | Prognostic |
| Cohort | Specimens from 72 clinically localized PCa cases with follow-up data (29 without recurrence and 43 with recurrence) and 17 clinically localized PCa without follow-up data were collected and frozen at the time of radical prostatectomy |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.0045 |
| Method Used | real-time PCR |
| Clinical | No |
| Remarks | Univariate Analysis |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | PAGE4 |